EHI
Eagle Health Investments Portfolio holdings
AUM
$405M
This Quarter Return
-10.28%
1 Year Return
+14.19%
3 Year Return
+134.25%
5 Year Return
–
10 Year Return
–
AUM
$454M
AUM Growth
+$454M
(-15%)
Cap. Flow
-$16.8M
Cap. Flow
% of AUM
-3.7%
Top 10 Holdings %
Top 10 Hldgs %
72.29%
Holding
27
New
–
Increased
7
Reduced
5
Closed
4
Top Buys
| 1 |
Lantheus
LNTH
|
$11.4M |
| 2 |
DexCom
DXCM
|
$10.6M |
| 3 |
Transmedics
TMDX
|
$9.97M |
| 4 |
Sarepta Therapeutics
SRPT
|
$9.32M |
| 5 |
Inspire Medical Systems
INSP
|
$4.05M |
Top Sells
| 1 |
CTLT
CATALENT, INC.
CTLT
|
$19.9M |
| 2 |
Intuitive Surgical
ISRG
|
$12.8M |
| 3 |
Tandem Diabetes Care
TNDM
|
$7.86M |
| 4 |
Guardant Health
GH
|
$7.12M |
| 5 |
Illumina
ILMN
|
$6.51M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Icon
ICLR
$13.8B
| $45.9M | 10.1% |
186,200
| – | – |
|
2
Danaher
DHR
$147B
| $43.4M | 9.57% |
175,085
+3,000
| +2% | +$744K |
|
3
IQVIA
IQV
$32.4B
| $40.5M | 8.93% |
206,095
-13,400
| -6% | -$2.64M |
|
4
United Therapeutics
UTHR
$13.8B
| $38.6M | 8.5% |
170,838
| – | – |
|
5
argenx
ARGX
$43.6B
| $31.7M | 6.98% |
64,400
| – | – |
|
|
6
Lantheus
LNTH
$3.73B
| $29M | 6.38% |
416,700
+163,500
| +65% | +$11.4M |
|
7
Natera
NTRA
$23.1B
| $26.4M | 5.81% |
595,694
| – | – |
|
|
8
DexCom
DXCM
$29.5B
| $25.8M | 5.68% |
276,105
+113,705
| +70% | +$10.6M |
|
9
Alnylam Pharmaceuticals
ALNY
$58.5B
| $24.2M | 5.34% |
136,756
| – | – |
|
|
10
Transmedics
TMDX
$3.92B
| $22.7M | 5% |
414,205
+182,173
| +79% | +$9.97M |
|
|
11
Sarepta Therapeutics
SRPT
$1.78B
| $21.1M | 4.65% |
174,212
+76,872
| +79% | +$9.32M |
|
|
12
Inspire Medical Systems
INSP
$2.77B
| $18.5M | 4.08% |
93,243
+20,400
| +28% | +$4.05M |
|
13
Outset Medical
OM
$247M
| $16.3M | 3.58% |
1,494,514
+294,129
| +25% | +$3.2M |
|
|
14
Illumina
ILMN
$15.8B
| $16.2M | 3.57% |
117,902
-47,398
| -29% | -$6.51M |
|
|
15
Intuitive Surgical
ISRG
$170B
| $12.7M | 2.79% |
43,390
-43,900
| -50% | -$12.8M |
|
16
Procept Biorobotics
PRCT
$2.23B
| $11.1M | 2.44% |
337,218
| – | – |
|
17
Agios Pharmaceuticals
AGIO
$2.19B
| $6.62M | 1.46% |
267,630
| – | – |
|
18
Adaptive Biotechnologies
ADPT
$2.01B
| $6.62M | 1.46% |
1,214,860
| – | – |
|
|
19
Guardant Health
GH
$8.41B
| $6.07M | 1.34% |
204,861
-240,300
| -54% | -$7.12M |
|
20
4D Molecular Therapeutics
FDMT
$288M
| $5.57M | 1.23% |
437,911
| – | – |
|
|
PNT
21
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
| $2.04M | 0.45% |
306,142
| – | – |
|
|
CMAX
22
DELISTED
CareMax, Inc. Class A Common Stock
CMAX
| $1.52M | 0.33% |
714,755
| – | – |
|
|
FUSN
23
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
| $1.51M | 0.33% |
579,769
-100,601
| -15% | -$262K |
|
24
American Well
AMWL
$111M
| – | – |
-1,395,039
| Closed | -$2.93M |
|
|
25
Tandem Diabetes Care
TNDM
$845M
| – | – |
-320,325
| Closed | -$7.86M |
|